Defliza 6mg Tablet DEFLAZACORT

Introduction to Defliza 6mg Tablet

Defliza 6mg Tablet is a medication primarily used to treat a condition known as Duchenne muscular dystrophy (DMD) in children aged 5 and older. This condition leads to muscle weakening, and Defliza helps manage the symptoms effectively.

Composition of Defliza 6mg Tablet

The active ingredient in Defliza 6mg Tablet is Deflazacort. It works by reducing inflammation and suppressing the immune system, which helps in managing the symptoms of DMD.

Uses of Defliza 6mg Tablet

• Management of Duchenne muscular dystrophy (DMD) in children.
• Reduces inflammation in the body.
• Suppresses the immune system to prevent further muscle damage.

Side effects of Defliza 6mg Tablet

Common side effects:

• Weight gain
• Increased appetite
• Round face (Cushingoid appearance)
• Upper respiratory infections (common cold)
• Frequent urination
• Nose and throat inflammation
• Excessive hair growth
• Irritability

Serious side effects:

• Allergic reactions such as rash, itching, or swelling
• Severe dizziness
• Trouble breathing

Precautions of Defliza 6mg Tablet

Defliza 6mg Tablet should not be taken by individuals who are allergic to Deflazacort or any of its ingredients. It should be used with caution during pregnancy and breastfeeding. Stopping the medication suddenly can lead to steroid withdrawal syndrome, which includes symptoms like loss of appetite, nausea, vomiting, tiredness, and headache.

How to Take Defliza 6mg Tablet

• Take the tablet once daily by mouth.
• The recommended dose is about 0.9 mg for each kilogram of body weight.
• It can be taken with or without food.
• Avoid taking it with grapefruit juice.

Conclusion of Defliza 6mg Tablet

Defliza 6mg Tablet is an effective medication for managing Duchenne muscular dystrophy in children. It helps reduce inflammation and suppresses the immune system to prevent further muscle damage. However, it is important to follow the prescribed dosage and take necessary precautions to avoid potential side effects.